FDA grants IDE for first miniaturized robotic-assisted surgery platform

Virtual Incision Corp. announced FDA approval of an Investigational Device Exemption supplement for its final stage clinical study of the MIRA Platform for bowel resection procedures.According to a company press release, MIRA is the first-of-its-kind, miniaturized robotic-assisted surgery (RAS) platform, which offers the benefits of RAS without the inefficiencies of traditional robotics. The platform received favorable interim trial safety profile reports.“MIRA was created to address the limitations of traditional robotic-assisted mainframe machines,” John Murphy, president andRead More

Related Articles